ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Haematology · Am J Hematol · 2026-07-02

In 153 adults with vitamin B12 deficiency anaemia randomised to intranasal, intravenous or intramuscular B12, all routes raised haemoglobin by day 28 (mean +2.48, +1.80, +2.18 g/dL) with no significant difference after adjustment; route did not predict response.

RCTn = 153
Singh et al. Comparative Efficacy of Intranasal, Intramuscular, and Intravenous Vitamin B12 Therapy for Hematological Recovery in Vitamin B12 Deficiency Anemia: A Randomized Controlled Trial
Haematology · Am J Hematol · 2026-01-19

Secondary analysis of COMMANDS (350 evaluable patients with transfusion-dependent lower-risk MDS): luspatercept gave higher transfusion response than epoetin alfa across mutations (risk difference 0.25, 95% CI 0.15-0.35); responses were similar in RS-negative patients.

Secondary analysisn = 350
Komrokji et al. Impact of Mutational Landscape and Burden on RBC Transfusion Response in Patients With Lower-Risk Myelodysplastic Syndromes (LR-MDS) in the COMMANDS Study

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.